Tempest Therapeutics, Inc. Income Taxes Paid
Tempest Therapeutics, Inc. (TPST) reported Income Taxes Paid of $152.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2023-11-08
- Tempest Therapeutics, Inc. income taxes paid for the quarter ending 2023-09-30 was $48.00K.
- Tempest Therapeutics, Inc. income taxes paid for the quarter ending 2023-06-30 was $80.00K.
- Tempest Therapeutics, Inc. income taxes paid for the quarter ending 2023-03-31 was $24.00K.
- Tempest Therapeutics, Inc. income taxes paid for the quarter ending 2022-12-31 was $18.00K.
- Tempest Therapeutics, Inc. income taxes paid for fiscal 2022 was $18.00K.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2023-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $128.00K derived: sum of 2 quarters · filed 2023-11-08 | $152.00K 10-Q · filed 2023-11-08 | $170.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $104.00K 10-Q · filed 2023-08-10 | $122.00K derived: sum of 3 quarters · filed 2023-08-10 | $122.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-03-31 | $24.00K 10-Q · filed 2023-05-10 | $42.00K derived: sum of 2 quarters · filed 2023-05-10 | $42.00K derived: sum of 3 quarters · filed 2023-11-08 | |
| 2022-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $18.00K derived: sum of 2 quarters · filed 2023-11-08 | $18.00K 10-K · filed 2023-03-22 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |